Back to results
US 2019/0194269 A1Published application
Polynucleotides and polypeptides useful for making alkaloid compounds
AssigneesIntrexon Corporation, Serturner Corp.
InventorsPeter James FACCHINI, Joseph E. TUCKER
Life of this patent
Estimating the term…
Abstract
Polynucleotides and polypeptides useful in the manufacture of a class of chemical compounds known as alkaloids are provided. The polynucleotides and polypeptides may be used to synthesize alkaloids, including reticuline, thebaine and morphine, in vivo and in vitro. The polynucleotides further may be used to examine the presence of the polynucleotides in a cell or a cell extract, and to modulate expression thereof in living cells.
Claims49
A composition comprising an isolated polynucleotide comprising a nucleic acid sequence selected from the group consisting of:
- (a) SEQ.ID NO:
- 1, SEQ.ID NO:
- 2, SEQ.ID NO:
- 3, SEQ.ID. NO:
- 4, SEQ.ID NO:
- 5, SEQ.ID NO:
- 6, SEQ.ID NO:
- 7, SEQ.ID. NO:
- 8, SEQ.ID NO:
- 9, SEQ.ID NO:
- 10, SEQ.ID NO:
- 11, SEQ.ID. NO:
- 12, SEQ.ID NO:
- 13, SEQ.ID NO:
- 14, SEQ.ID NO:
- 15, SEQ.ID. NO:
- 16, SEQ.ID NO:
- 17, SEQ.ID NO:
- 18, SEQ.ID NO:
- 19, SEQ.ID. NO:
- 20, SEQ.ID NO:
- 21, SEQ.ID NO:
- 22, and SEQ.ID NO:
- 23, SEQ.ID NO:
- 47, SEQ.ID NO:
- 48, SEQ.ID NO:
- 49, SEQ.ID. NO:
- 50, SEQ.ID NO:
- 51, SEQ.ID NO:
- 52, SEQ.ID NO:
- 53, SEQ.ID. NO:
- 54, SEQ.ID NO:
- 55, SEQ.ID NO:
- 56, SEQ.ID NO:
- 57, SEQ.ID. NO:
- 58, SEQ.ID NO:
- 59, SEQ.ID NO:
- 60, SEQ.ID. NO:
- 75, SEQ.ID NO:
- 76, SEQ.ID NO:
- 77, SEQ.ID NO:
- 78, SEQ.ID. NO:
- 79, SEQ.ID NO:
- 80, SEQ.ID NO:
- 81, SEQ.ID NO:
- 82, SEQ.ID NO:
- 83, SEQ.ID NO:
- 84, SEQ.ID. NO:
- 85, SEQ.ID NO:
- 86, SEQ.ID NO:
- 87, SEQ.ID NO:
- 88, SEQ.ID. NO:
- 89, SEQ.ID NO:
- 90, SEQ.ID NO:
- 91, SEQ.ID NO:
- 92, SEQ.ID NO:
- 93;
- SEQ.ID NO:
- 113 to SEQ.ID NO:
- 505 or SEQ.ID. NO:
- 766;
- (b) a nucleic acid sequence that is substantially identical to any one of the nucleic acid sequences of (a);
- (c) a nucleic acid sequence that is substantially identical to any one of the nucleic acid sequences of (a) but for the degeneration of the genetic code;
- (d) a nucleic acid sequence that is complementary to any one of the nucleic acid sequences of (a);
- (e) a nucleic acid sequence encoding a polypeptide having any one of the amino acid sequences set forth in SEQ.ID NO:
- 24, SEQ.ID NO:
- 25, SEQ.ID NO:
- 26, SEQ.ID. NO:
- 27, SEQ.ID NO:
- 28, SEQ.ID NO:
- 29, SEQ.ID NO:
- 30, SEQ.ID. NO:
- 31, SEQ.ID NO:
- 32, SEQ.ID NO:
- 33, SEQ.ID NO:
- 34, SEQ.ID. NO:
- 35, SEQ.ID NO:
- 36, SEQ.ID NO:
- 37, SEQ.ID NO:
- 38, SEQ.ID. NO:
- 39, SEQ.ID NO:
- 40, SEQ.ID NO:
- 41, SEQ.ID NO:
- 42, SEQ.ID. NO:
- 43, SEQ.ID NO:
- 44, SEQ.ID NO:
- 45, SEQ.ID NO:
- 46, SEQ.ID NO:
- 61, SEQ.ID NO:
- 62, SEQ.ID NO:
- 63, SEQ.ID NO:
- 64, SEQ.ID. NO:
- 65, SEQ.ID NO:
- 66, SEQ.ID NO:
- 67, SEQ.ID NO:
- 68, SEQ.ID. NO:
- 69, SEQ.ID NO:
- 70, SEQ.ID NO:
- 71, SEQ.ID NO:
- 72, SEQ.ID. NO:
- 73, SEQ.ID NO:
- 74, SEQ.ID. NO:
- 94, SEQ.ID NO:
- 95, SEQ.ID NO:
- 96, SEQ.ID NO:
- 97, SEQ.ID. NO:
- 98, SEQ.ID NO:
- 99, SEQ.ID NO:
- 100, SEQ.ID NO:
- 101, SEQ.ID NO:
- 102, SEQ.ID NO:
- 103, SEQ.ID. NO:
- 104, SEQ.ID NO:
- 105, SEQ.ID NO:
- 106, SEQ.ID NO:
- 107, SEQ.ID. NO:
- 108, SEQ.ID NO:
- 109, SEQ.ID NO:
- 110, SEQ.ID NO:
- 111, SEQ.ID NO:
- 112, SEQ.ID NO:
- 506 to SEQ.ID NO:
- 765 or SEQ.ID NO:
- 768 to SEQ.ID NO:
- 901;
- (f) a nucleic acid sequence that encodes a functional variant of any one of the amino acid sequences set forth in SEQ.ID NO:
- 24, SEQ.ID NO:
- 25, SEQ.ID NO:
- 26, SEQ.ID. NO:
- 27, SEQ.ID NO:
- 28, SEQ.ID NO:
- 29, SEQ.ID NO:
- 30, SEQ.ID. NO:
- 31, SEQ.ID NO:
- 32, SEQ.ID NO:
- 33, SEQ.ID NO:
- 34, SEQ.ID. NO:
- 35, SEQ.ID NO:
- 36, SEQ.ID NO:
- 37, SEQ.ID NO:
- 38, SEQ.ID. NO:
- 39, SEQ.ID NO:
- 40, SEQ.ID NO:
- 41, SEQ.ID NO:
- 42, SEQ.ID. NO:
- 43, SEQ.ID NO:
- 44, SEQ.ID NO:
- 45, SEQ.ID NO:
- 46, SEQ.ID NO:
- 61, SEQ.ID NO:
- 62, SEQ.ID NO:
- 63, SEQ.ID NO:
- 64, SEQ.ID. NO:
- 65, SEQ.ID NO:
- 66, SEQ.ID NO:
- 67, SEQ.ID NO:
- 68, SEQ.ID. NO:
- 69, SEQ.ID NO:
- 70, SEQ.ID NO:
- 71, SEQ.ID NO:
- 72, SEQ.ID. NO:
- 73, SEQ.ID NO:
- 74, SEQ.ID. NO:
- 94, SEQ.ID NO:
- 95, SEQ.ID NO:
- 96, SEQ.ID NO:
- 97, SEQ.ID. NO:
- 98, SEQ.ID NO:
- 99, SEQ.ID NO:
- 100, SEQ.ID NO:
- 101, SEQ.ID NO:
- 102, SEQ.ID NO:
- 103, SEQ.ID. NO:
- 104, SEQ.ID NO:
- 105, SEQ.ID NO:
- 106, SEQ.ID NO:
- 107, SEQ.ID. NO:
- 108, SEQ.ID NO:
- 109, SEQ.ID NO:
- 110, SEQ.ID NO:
- 111, SEQ.ID NO:
- 112, SEQ.ID NO:
- 506 to SEQ.ID NO:
- 765 or SEQ.ID NO:
- 768 to SEQ.ID NO:
- 901;
- and
- (g) a nucleic acid sequence that hybridizes under stringent conditions to any one of the nucleic acid sequences set forth in (a), (b), (c), (d), (e) or (f).
185 more elements
Dependencies are inferred from the claim text.